2021 financial calendar for ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF):
Silent period | |
Annual report 2020 | |
Annual General Meeting to be held at ALK Bøge Allé 1 2970 Hørsholm, Written requests to have specific business transacted at the AGM will be included in the agenda if received by the company on (may be e-mailed to investor@alk.net) | |
Silent period | |
Three-month interim report (Q1) 2021 | |
Silent period | |
Six-month interim report (Q2) 2021 | |
Silent period | |
Nine-month interim report (Q3) 2021 |
ALK-Abelló A/S
For further information please contact:
Investor Relations: Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525
Media: Jeppe Ilkjær, mobile +45 3050 2014
About ALK
ALK is a global specialty pharmaceutical company focused on allergy and allergic asthma. It markets allergy immunotherapy treatments and other products and services for people with allergy and allergy doctors. Headquartered in Hørsholm,
Attachment
- InvestorNews_17Dec20
© OMX, source